Rose Hughes
unpacked the UPC Brussels local division's handling of 2seventy bio v Johnson & Johnson, the first pharmaceutical case for that division, walking through the sequence-based patent claims at stake in the CAR-T cell therapy space and what the litigation signals for how the UPC will approach complex biotech disputes.
Claire Gregg
reported on a Federal Court of Australia decision ordering the withdrawal of patent applications prior to their publication, an unusual remedy that raises pointed questions about the boundaries of the court's power to intervene in the prosecution process before a patent even grants.
Claire also
explored the nuances of divisional patent practice in Australia and New Zealand, unpacking the procedural and strategic differences that practitioners need to keep in mind when filing across both jurisdictions.
Trade marks
Former GuestKat Darren Meale
surveyed the eighteenth volume of Retromark, his bi-annual roundup of the most notable trade mark cases from the previous six months across the UK and EU.
IP News and Events
Eleonora Rosati
announced that the Life Science Legal Strategy Summit has relocated to Frankfurt, with an IPKat discount available on the early bird rate for readers who want to attend.
Marcel Pemsel
rounded up the week in Sunday Surprises, flagging a new minister with responsibility for IP in the UK, a copyright litigation role at Sumfinity, and upcoming events including the 10th European IP Forum in Brussels and EPO Opposition Matters 2026.
